We would love to hear your thoughts about our site and services, please take our survey here.
"You can't argue the incompetence part though"
Who said running a listed company was easy - alot of nuanced decisions way over the heads of the majority of PI investors.
The good news is spouting/venting shareholders have no real power. All they do is sour the short term sentiment of our investment. Bit sad really but at the end of the day a self correcting mechanism as they convince themselves to leave.
"Don’t agree with the note in the RNS about future cash payments being possible, that seems to be buckling under pressure from the shareholder groups that are complaining. Would have preferred they stayed silent, seems a little unprofessional."
I think it's called diplomacy.
@JT
What are the disadvantages to the FDA of approval after P1a with confirmatory P2/3
Let clinicians decide, where Dox is/ would be the chosen treatment to use a safer better quality of life substitute if they choose for their particular patient ?
"..not sure where you get your reason for talking about someone's margin call... "
Because, despite some good base research, imo MM is not the solution to volatility in Avacta's SP but part of the problem. So a large ill judged margin position is "part of the ball"
At the end of the day he doesn't do himself, or his followers, any favours!
"As was pointed out at the time by MM amongst others (probably yourself included), the DX acquisition was a terrible use of the companies' resources, "
NOT true MM lauded the purchase at the time - changed his tune end of last year.
Threw all his toys out the pram after losing £50k on a poor margin trade earlier this year.
"My understanding was that avacta have the option to repay in cash."
Yes i believe that is correct. My understanding is that Heights have the right to convert any amount at anytime - subject to Avacta repaying in cash if they have it.
Do Avacta have a spare £38m ?